Ad4-Env150KN
/ National Institute of Allergy and Infectious Diseases
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
October 30, 2025
Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=300 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Trial completion date: Oct 2025 ➔ Oct 2026 | Trial primary completion date: Oct 2025 ➔ Oct 2026
Trial completion date • Trial primary completion date • Human Immunodeficiency Virus • Infectious Disease
April 26, 2025
Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=300 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Trial completion date: Apr 2025 ➔ Oct 2025 | Trial primary completion date: Apr 2025 ➔ Oct 2025
Trial completion date • Trial primary completion date • Human Immunodeficiency Virus • Infectious Disease
May 03, 2024
Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=300 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Trial completion date: Apr 2024 ➔ Apr 2025 | Trial primary completion date: Apr 2024 ➔ Apr 2025
Trial completion date • Trial primary completion date • Human Immunodeficiency Virus • Infectious Disease
1 to 3
Of
3
Go to page
1